搜尋
Lipella Pharmaceuticals Inc
LIPO添加自選
2.360USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
6.02M總市值
虧損本益比TTM
關於 Lipella Pharmaceuticals Inc 公司
Lipella Pharmaceuticals Inc. 是一家臨牀階段的生物技術公司。該公司專注於通過重新配製現有仿製藥中的活性成分並針對新應用優化這些重新配製來開發新藥。其主要候選產品包括 LP-10、LP-310 和 LP-410。LP-10 是其重新配製的他克莫司的開發名稱，該名稱專門針對使用專有藥物輸送平臺局部沉積到膀胱腔內表面進行了優化。LP-310 是其口服脂質體他克莫司的開發名稱，該名稱專門針對局部輸送到口腔粘膜進行了優化。該公司還在開發一種口服脂質體他克莫司製劑 LP-410，用於治療口腔移植物抗宿主病 (GVHD)。LP-410 是一種口腔漱口水，與 LP-310 類似，但具有不同的密封系統。 LP-410 針對口服 GVHD 的潛在機制，可能爲受影響的個體提供安全有效的治療選擇。
Lipella Pharmaceuticals Inc簡介
公司代碼LIPO
公司名稱Lipella Pharmaceuticals Inc
上市日期Dec 20, 2022
CEODr. Jonathan H Kaufman, Ph.D.
員工數量5
證券類型Ordinary Share
年結日Dec 20
公司地址400 N Lexington St Ste LL103
城市PITTSBURGH
上市交易所US 'Other OTC' and Grey Market
國家United States of America
郵編15208
電話14129010315
網址https://lipella.com/
公司代碼LIPO
上市日期Dec 20, 2022
CEODr. Jonathan H Kaufman, Ph.D.
Lipella Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jonathan H Kaufman, Ph.D.
Dr. Jonathan H Kaufman, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
112.35K
--
Dr. Byeong (Christopher) Kim, Ph.D.
Dr. Byeong (Christopher) Kim, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lori A. Birder, Ph.D.
Dr. Lori A. Birder, Ph.D.
Independent Director
Independent Director
--
--
Mr. Douglas Johnston, CPA
Mr. Douglas Johnston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Naoki Yoshimura, M.D., Ph.D.
Dr. Naoki Yoshimura, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Daniel Cohen
Mr. Daniel Cohen
Independent Director
Independent Director
--
--
Mr. Ryan Pruchnic
Mr. Ryan Pruchnic
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Jonathan H Kaufman, Ph.D.
Dr. Jonathan H Kaufman, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
112.35K
--
Dr. Byeong (Christopher) Kim, Ph.D.
Dr. Byeong (Christopher) Kim, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lori A. Birder, Ph.D.
Dr. Lori A. Birder, Ph.D.
Independent Director
Independent Director
--
--
Mr. Douglas Johnston, CPA
Mr. Douglas Johnston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Naoki Yoshimura, M.D., Ph.D.
Dr. Naoki Yoshimura, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Daniel Cohen
Mr. Daniel Cohen
Independent Director
Independent Director
--
--
常見問題
Lipella Pharmaceuticals Inc的前五大股東是誰？
Lipella Pharmaceuticals Inc的前五大股東如下：Dr. Jonathan H Kaufman, Ph.D.
有多少機構持有Lipella Pharmaceuticals Inc(LIPO)的股份？
截至2026Q1，共有13家機構持有Lipella Pharmaceuticals Inc的股份，合計持有的股份價值約為60.33K，占公司總股份的1.31% 。與2025Q4相比，機構持股有所增加，增幅為29053.00。